Study Title
Open-Label Study of 18F-mFBG for Imaging Neuroblastoma
Study Details
Description:
This is a Phase 3 study evaluating the positron-emitting radiopharmaceutical 18F-mFBG as an imaging agent for confirming or excluding the presence of neuroblastoma
Sponsor:
Innervate Radiopharmacueticals LLC
Government Study Link:
NCT04724369 - Click here to see study onClinicalTrials.gov